JUBILANT Management Evaluation

<div class='circular--portrait' style='background:#006400;color: #FFE4E1;font-size:4em;padding-top: 25px;;'>JL</div>
JUBILANT -- India Stock  

INR 679.65  15.00  2.26%

JUBILANT LIFE employes about 8 K people. The company is managed by 1 executives with total tenure of roughly 18667 years, averaging almost 18667.0 years of service per executive having 8000.0 employees per reported executive. Inspection of JUBILANT LIFE management performance can provide insight into the company performance. Note, employee sentiment is becoming a valuable factor that investors use to determine the amount of risk that may be associated with JUBILANT LIFE SCIE future performance. Please see Risk vs Return Analysis.

Search Insiders

Sr. VP of Corporate Affairs

JUBILANT LIFE Management Team Effectiveness

JUBILANT LIFE SCIE has return on total asset (ROA) of 7.74 % which means that it generated profit of $7.74 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE) of 17.25 %, meaning that it generated $17.25 on every $100 dollars invested by stockholders. JUBILANT LIFE management efficiency ratios could be used to measure of how well the company is managing its routine affairs as well as how well it utilizes its assets and manages liabilities.

JUBILANT LIFE Workforce Comparison

JUBILANT LIFE SCIE is currently regarded as number one stock in number of employees category among related companies. The total workforce of Drug Manufacturers?Specialty & Generic industry is currently estimated at about 16,000. JUBILANT LIFE totals roughly 8,000 in number of employees claiming about 50% of equities under Drug Manufacturers?Specialty & Generic industry.

JUBILANT LIFE Profit Margins

The company has Profit Margin (PM) of 9.81 %, which can be a sign that it executes well on its competitive strategies and has a good control over its expenditures. This is very large. Similarly, it shows Operating Margin (OM) of 16.22 % which suggests for every 100 dollars of sales it generated a net operating income of 0.16.

JUBILANT LIFE SCIE Benchmark Summation

The output start index for this execution was zero with a total number of output elements of sixty-one. JUBILANT LIFE SCIE Price Series Summation is a cross summation of JUBILANT LIFE price series and its benchmark/peer. View also all equity analysis or get more info about price series summation math operators indicator.


A BA Sr. VP of Corporate Affairs

About JUBILANT LIFE Management Performance

The success or failure of an entity such as JUBILANT LIFE SCIE often depends on how effective the management is. JUBILANT LIFE management team is responsible for propelling the future growth in the right direction and for administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of JUBILANT management before purchasing its stock. It's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the JUBILANT management is utilizing all available resources in the best possible way? Also, how well is the company doing, relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity. Please read more on our stock advisor page.
Jubilant Life Sciences Limited operates as an integrated pharmaceutical and life sciences company worldwide. The company was incorporated in 1978 and is based in Noida, India. JUBILANT LIFE operates under Drug ManufacturersSpecialty Generic classification in India and is traded on National Stock Exchange of India. It employs 8000 people.

JUBILANT LIFE Manpower Efficiency

Return on JUBILANT LIFE Manpower

Revenue Per Employee11.4 M
Net Income Per Employee1.1 M
Working Capital Per Employee483.5 K
Please see Risk vs Return Analysis. Please also try Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page